Patents by Inventor Sukhbinder Dhesy-Thind

Sukhbinder Dhesy-Thind has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Dronedarone and derivatives thereof for treating cancer
    Patent number: 11872207
    Abstract: The present application relates to methods of using compounds of Formulae (I) and (II): for treatment of various cancers. The application further relates to pharmaceutical compositions and uses comprising the compounds of the application.
    Type: Grant
    Filed: January 31, 2020
    Date of Patent: January 16, 2024
    Assignee: MCMASTER UNIVERSITY
    Inventors: Katarzyna Jerzak, Sukhbinder Dhesy-Thind, Anita Bane, Jessica Cockburn, John Hassell
  • COMPOUNDS FOR TREATING CANCER
    Publication number: 20200163930
    Abstract: The present application relates to methods of using compounds of Formulae (I) and (II): for treatment of various cancers. The application further relates to pharmaceutical compositions and uses comprising the compounds of the application.
    Type: Application
    Filed: January 31, 2020
    Publication date: May 28, 2020
    Applicant: McMaster University
    Inventors: Katarzyna Jerzak, Sukhbinder Dhesy-Thind, Anita Bane, Jessica Cockburn, John Hassell
  • Compounds for treating cancer and methods of use thereof
    Patent number: 10576056
    Abstract: Two isoforms of thyroid receptor alpha (THR?1 and THR?2) have been found to be associated with the growth of cancer. Use of inhibitors of THR?1 (Formula I) and/or agonists of THR?2 (Formula II) in the treatment of such cancers is disclosed. Treatment of other disorders associated with such receptors is also contemplated, as is the use of diagnostic methods for predicting therapeutic outcomes based on the levels of expression of THR?1 and THRa?2 in a tissue sample.
    Type: Grant
    Filed: December 22, 2016
    Date of Patent: March 3, 2020
    Assignee: McMaster University
    Inventors: Sukhbinder Dhesy-Thind, Katarzyna J. Jerzak, Anita Bane, Jessica G. Cockburn, John A. Hassell
  • COMPOUNDS FOR TARGETING THYROID HORMONE RECEPTOR ALPHA ISOFORMS AND METHODS OF USE THEREOF
    Publication number: 20180369190
    Abstract: Two isoforms of thyroid receptor alpha (THR?1 and THR?2) have been found to be associated with the growth of cancer. Use of inhibitors of THR?1 (Formula I) and/or agonists of THR?2 (Formula II) in the treatment of such cancers is disclosed. Treatment of other disorders associated with such receptors is also contemplated, as is the use of diagnostic methods for predicting therapeutic outcomes based on the levels of expression of THR?1 and THRa?2 in a tissue sample.
    Type: Application
    Filed: December 22, 2016
    Publication date: December 27, 2018
    Applicant: MCMASTER UNIVERSITY
    Inventors: Sukhbinder Dhesy-Thind, Katarzyna J. Jerzak, Anita Bane, Jessica G. Cockburn, John A. Hassell